ArcDia International Oy Ltd has been founded for production, marketing and sales of ArcDia TPX diagnostics products. ArcDia has developed a new concept for diagnosis of respiratory infections

Luxcel Biosciences Ltd has acquired exclusive business rights to ArcDia TRF porphyrin technology, read more ...

ArcDia Ltd introduces a new ArcDia MRSA technique for rapid screening of Methicillin resistant Staphylycoccus aureus

ArcDia's Distributed Diagnostics concept offers decentralised clinical chemistry and immuno diagnostics for doctor's offices and health centers.

Investment opportunity We are looking for investments to speed up the market entry of ArcDia MRSA screening and ArcDia TPX Distributed Diagnostics. Please call ArcDia for more information +358400520643